KCNH2 and breast carcinoma: In this study, we demonstrate that novel hERG activators, SDUY429 and SDUY436, significantly suppressed the proliferation of MDA-MB-231 breast cancer cells by activating the NFAT/p21 signaling pathway and inducing cell apoptosis.